These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 2158398

  • 1. Chromosome analysis of 31 Wilms' tumors.
    Sheng WW, Soukup S, Bove K, Gotwals B, Lampkin B.
    Cancer Res; 1990 May 01; 50(9):2786-93. PubMed ID: 2158398
    [Abstract] [Full Text] [Related]

  • 2. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
    Kaneko Y, Homma C, Maseki N, Sakurai M, Hata J.
    Cancer Res; 1991 Nov 01; 51(21):5937-42. PubMed ID: 1657374
    [Abstract] [Full Text] [Related]

  • 3. Chromosome abnormalities in tumor cells from patients with sporadic Wilms' tumor.
    Kondo K, Chilcote RR, Maurer HS, Rowley JD.
    Cancer Res; 1984 Nov 01; 44(11):5376-81. PubMed ID: 6091875
    [Abstract] [Full Text] [Related]

  • 4. [Cytogenetic findings in Wilms' tumor].
    Hohenfellner K, Holl M, Gutjahr P, Zabel B.
    Klin Padiatr; 1989 Nov 01; 201(4):293-8. PubMed ID: 2550699
    [Abstract] [Full Text] [Related]

  • 5. Effects of chemotherapy on the cytogenetic constitution of Wilms' tumor.
    Schlomm T, Gunawan B, Schulten HJ, Sander B, Thangavelu K, Graf N, Leuschner I, Ringert RH, Füzesi L.
    Clin Cancer Res; 2005 Jun 15; 11(12):4382-7. PubMed ID: 15958621
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetics of Wilms' tumor.
    Coppes MJ, Egeler RM.
    Semin Urol Oncol; 1999 Feb 15; 17(1):2-10. PubMed ID: 10073400
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cytogenetic findings and clinical course in a consecutive series of Wilms tumors.
    Kullendorff CM, Soller M, Wiebe T, Mertens F.
    Cancer Genet Cytogenet; 2003 Jan 01; 140(1):82-7. PubMed ID: 12550766
    [Abstract] [Full Text] [Related]

  • 11. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
    Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC.
    Cancer Res; 1994 May 01; 54(9):2331-3. PubMed ID: 8162576
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cytogenetic changes in Wilms' tumors.
    Solis V, Pritchard J, Cowell JK.
    Cancer Genet Cytogenet; 1988 Sep 01; 34(2):223-34. PubMed ID: 2842036
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F, Teixeira MR, Haugom L, Kristensen G, Abeler VM, Heim S.
    Genes Chromosomes Cancer; 2004 Jul 01; 40(3):229-46. PubMed ID: 15139002
    [Abstract] [Full Text] [Related]

  • 19. Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells.
    Fraizer GE, Bowen-Pope DF, Vogel AM.
    J Cell Physiol; 1987 Oct 01; 133(1):169-74. PubMed ID: 2444606
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.